Gaston Roustan-Gullón
Gaston Roustan-Gullón has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Fernando Alfageme
Department of Dermatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain
5 shared publications - Francisco José Rodríguez-Cuadrado
Department of Dermatology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
5 shared publications - Ángel Manuel Rosell-Díaz
Department of Dermatology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
4 shared publications - Marta Elosua‐González
Department of Dermatology Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
3 shared publications - Constanza Martinez-Mera
Dermatology Department Hospital Universitario Puerta de Hierro Majadahonda Madrid Spain
2 shared publications - Dolores Suárez-Massa
Department of Pathology, Hospital Universitario Puerta de Hierro Majadahonda, Majadahonda, Spain
2 shared publications
Latest Publications
- Open Access
- 8 October 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (1) , 82-90
Artificial Intelligence‐Based Quantification to Assess the Automatic Psoriasis Area and Severity Index
Background: Psoriasis is a chronic inflammatory skin condition affecting millions globally, traditionally assessed via the Psoriasis Area and Severity Index (PASI). Despite its widespread use, PASI suffers from subjectivity, limited sensitivity for small lesions, and high interobserver variability. Recent advances in artificial intelligence offer a promising route to overcome these limitations. Objectives: This study aimed to develop and validate the Automatic Psoriasis Area and Severity Index (APASI), an AI‐driven system for rapid, objective, and standardised assessment of psoriasis severity. Methods: We compiled the Legit.Health‐PsO‐PASI dataset, consisting of 2857 images spanning various disease severities and annotated by three expert dermatologists. Two deep learning modules were developed: one for lesion segmentation and another for visual sign intensity classification (erythema, induration and desquamation). Multiple encoder architectures, including ResNet, SE_ResNeXt, Xception, Inceptionv4, EfficientNet, and SegFormer, were evaluated using a five‐fold cross‐validation approach. Performance metrics included accuracy, root mean square error, intersection over union, confusion matrices and Cohen's kappa for assessing interobserver variability. Results: The best‐performing model, MiT_b2, achieved human‐comparable performance, with accuracies of 60.6% for erythema, 54.3% for induration, and 61.8% for desquamation. For lesion segmentation, the Xception model outperformed expert dermatologists, achieving an intersection over union of 0.752. Conclusions: APASI provides a robust AI‐driven framework for psoriasis severity assessment, delivering rapid, objective, and precise evaluations. Its integration into clinical and research workflows could enhance disease monitoring, improve treatment assessment and reduce evaluation costs.
- 8 October 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 5 (1) , 82-90
Open AccessArtificial Intelligence‐Based Quantification to Assess the Automatic Psoriasis Area and Severity Index
Background: Psoriasis is a chronic inflammatory skin condition affecting millions globally, traditionally assessed via the Psoriasis Area and Severity Index (PASI). Despite its widespread use, PASI suffers from subjectivity, limited sensitivity for small lesions, and high interobserver variability. Recent advances in artificial intelligence offer a promising route to overcome these limitations. Objectives: This study aimed to develop and validate the Automatic Psoriasis Area and Severity Index (APASI), an AI‐driven system for rapid, objective, and standardised assessment of psoriasis severity. Methods: We compiled the Legit.Health‐PsO‐PASI dataset, consisting of 2857 images spanning various disease severities and annotated by three expert dermatologists. Two deep learning modules were developed: one for lesion segmentation and another for visual sign intensity classification (erythema, induration and desquamation). Multiple encoder architectures, including ResNet, SE_ResNeXt, Xception, Inceptionv4, EfficientNet, and SegFormer, were evaluated using a five‐fold cross‐validation approach. Performance metrics included accuracy, root mean square error, intersection over union, confusion matrices and Cohen's kappa for assessing interobserver variability. Results: The best‐performing model, MiT_b2, achieved human‐comparable performance, with accuracies of 60.6% for erythema, 54.3% for induration, and 61.8% for desquamation. For lesion segmentation, the Xception model outperformed expert dermatologists, achieving an intersection over union of 0.752. Conclusions: APASI provides a robust AI‐driven framework for psoriasis severity assessment, delivering rapid, objective, and precise evaluations. Its integration into clinical and research workflows could enhance disease monitoring, improve treatment assessment and reduce evaluation costs.
- Open Access
- 31 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Retrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records
We conducted a multicenter retrospective analysis of 408 patients diagnosed with onychomycosis who attended three tertiary care Spanish hospitals. The study was conducted to assess the clinical characteristics and outcomes of onychomycosis patients undertaken combined treatment with ciclopirox 8% hydroxypropyl chitosan (CPX 8% HPCH) nail lacquer and oral antifungal agents (terbinafine, itraconazole, and fluconazole). Data were extracted and analyzed using the EHRead® technology based on natural language processing and machine learning and using SNOMED CT terminology. The mean age was 51.1 years, with 54.4% females. Repeated nail trauma was the most common risk factor (7.1%). More than half of the patients (56.6%) underwent fungal culture. Terbinafine, itraconazole, and fluconazole were used in 67.7%, 20.8%, and 11.5% of patients, respectively. Treatment synchronicity distribution revealed that 59.1% of patients started concomitant treatment with CPX 8% HPCH and oral antifungals, 27.9% had initial oral antifungals, and 13% had initial nail lacquer. The response to treatment (positive response 15.7%, presumed positive 59.8%) was unrelated to treatment synchronicity or type of antifungal agent. Erythema (5.6%), diarrhea (4.9%), and fever (4.2%) were the most frequently registered potential adverse events. These findings provide valuable insights for physicians regarding the management of patients with onychomycosis in daily practice.
- 31 July 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-14
Open AccessRetrospective study of onychomycosis patients treated with ciclopirox 8% HPCH and oral antifungals applying artificial intelligence to electronic health records
We conducted a multicenter retrospective analysis of 408 patients diagnosed with onychomycosis who attended three tertiary care Spanish hospitals. The study was conducted to assess the clinical characteristics and outcomes of onychomycosis patients undertaken combined treatment with ciclopirox 8% hydroxypropyl chitosan (CPX 8% HPCH) nail lacquer and oral antifungal agents (terbinafine, itraconazole, and fluconazole). Data were extracted and analyzed using the EHRead® technology based on natural language processing and machine learning and using SNOMED CT terminology. The mean age was 51.1 years, with 54.4% females. Repeated nail trauma was the most common risk factor (7.1%). More than half of the patients (56.6%) underwent fungal culture. Terbinafine, itraconazole, and fluconazole were used in 67.7%, 20.8%, and 11.5% of patients, respectively. Treatment synchronicity distribution revealed that 59.1% of patients started concomitant treatment with CPX 8% HPCH and oral antifungals, 27.9% had initial oral antifungals, and 13% had initial nail lacquer. The response to treatment (positive response 15.7%, presumed positive 59.8%) was unrelated to treatment synchronicity or type of antifungal agent. Erythema (5.6%), diarrhea (4.9%), and fever (4.2%) were the most frequently registered potential adverse events. These findings provide valuable insights for physicians regarding the management of patients with onychomycosis in daily practice.
- 4 November 2024
- Published by Springer Nature in Journal of Ultrasound
- Vol. 28 (1) , 137-150
Trichosonography: ultrasound of alopecias and hair disorders
Trichology is the area of dermatology that focuses on the study, diagnosis and management of the different types of alopecia and hair and scalp disorders. In recent years, there have been great advances in the non-invasive diagnosis of these conditions, especially with trichoscopy and more recently with sonography. High frequency ultrasound study of the scalp, for which we propose the name of “trichosonography”, may represent a valuable technique in the evaluation of both clinical and subclinical abnormalities of the hair follicle and the innermost layers of the skin, which are otherwise inaccessible to trichoscopy. The purpose of this pictorial essay is to offer a descriptive approach to the clinical and ultrasound findings of the main hair and scalp disorders.
- 4 November 2024
- Published by Springer Nature in Journal of Ultrasound
- Vol. 28 (1) , 137-150
Trichosonography: ultrasound of alopecias and hair disorders
Trichology is the area of dermatology that focuses on the study, diagnosis and management of the different types of alopecia and hair and scalp disorders. In recent years, there have been great advances in the non-invasive diagnosis of these conditions, especially with trichoscopy and more recently with sonography. High frequency ultrasound study of the scalp, for which we propose the name of “trichosonography”, may represent a valuable technique in the evaluation of both clinical and subclinical abnormalities of the hair follicle and the innermost layers of the skin, which are otherwise inaccessible to trichoscopy. The purpose of this pictorial essay is to offer a descriptive approach to the clinical and ultrasound findings of the main hair and scalp disorders.
- Open Access
- 1 September 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (5) , 783-785
Penfigoide bolhoso, psoríase e artrite psoriásica multirrefratários ao tratamento com resposta bem sucedida ao guselcumabe
- 1 September 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 99 (5) , 783-785
Open AccessPenfigoide bolhoso, psoríase e artrite psoriásica multirrefratários ao tratamento com resposta bem sucedida ao guselcumabe
- Open Access
- 13 June 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (5) , 783-785
Multirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab
- 13 June 2024
- Published by Elsevier in Anais Brasileiros de Dermatologia
- Vol. 99 (5) , 783-785
Open AccessMultirefractory bullous pemphigoid, psoriasis and psoriatic arthritis successfully treated with guselkumab
- 1 December 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (6) , 720-722
Dermpath: Eruptive syringoma mimicking cutaneous mastocytosis
- 1 December 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (6) , 720-722
Dermpath: Eruptive syringoma mimicking cutaneous mastocytosis
- 1 June 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (3) , 329-332
Dermpath: Extraosseous Ewing sarcoma with cutaneous metastases
- 1 June 2023
- Published by JLE in European Journal Of Dermatology
- Vol. 33 (3) , 329-332
Dermpath: Extraosseous Ewing sarcoma with cutaneous metastases
- 26 January 2023
- Published by Springer Nature in Journal of Ultrasound
- Vol. 26 (1) , 307-311
Sonography of monkeypox cutaneous lesions
The present global outbreak of monkeypox has reached more than 79,000 cases by November 2022. While clinical features have been extensively studied, ultrasound findings in monkeypox skin lesions have not been described to date. In our work, we performed a complete sonographic study with Doppler and elastography of 3 patients with polymerase chain reaction-proven monkeypox. The most characteristic findings in skin lesions were hyperechoic epidermal thickening, dermo-hypodermal thickening with focal hypoechogenicity and increased intralesional vascularization. Regarding lymphadenopathies, we found vascularization of hilar distribution and an increased cortical stiffness and shoft hiliar area.
- 26 January 2023
- Published by Springer Nature in Journal of Ultrasound
- Vol. 26 (1) , 307-311
Sonography of monkeypox cutaneous lesions
The present global outbreak of monkeypox has reached more than 79,000 cases by November 2022. While clinical features have been extensively studied, ultrasound findings in monkeypox skin lesions have not been described to date. In our work, we performed a complete sonographic study with Doppler and elastography of 3 patients with polymerase chain reaction-proven monkeypox. The most characteristic findings in skin lesions were hyperechoic epidermal thickening, dermo-hypodermal thickening with focal hypoechogenicity and increased intralesional vascularization. Regarding lymphadenopathies, we found vascularization of hilar distribution and an increased cortical stiffness and shoft hiliar area.
- 15 December 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (5) , E678-E680
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study
- 15 December 2022
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (5) , E678-E680
Drug survival of adalimumab biosimilar vs adalimumab originator in hidradenitis suppurativa: Can equivalence be assumed? A retrospective cohort study
- Open Access
- 1 May 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (3) , 358-361
Remissão clínica de infecção disseminada por molusco contagioso em paciente com dermatite atópica tratada com dupilumabe
- 1 May 2022
- Published by Elsevier in Anais Brasileiros de Dermatologia (Versão em Português)
- Vol. 97 (3) , 358-361
Open AccessRemissão clínica de infecção disseminada por molusco contagioso em paciente com dermatite atópica tratada com dupilumabe